Seagen Appoints David Epstein As New CEO
WASHINGTON (dpa-AFX) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board
Source: finanznachrichten.de